Recent advances in nanoparticle applications in respiratory disorders: a review
ME Taghavizadeh Yazdi, M Qayoomian… - Frontiers in …, 2023 - frontiersin.org
Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …
Aerosol pulmonary immune engineering
ER Sudduth, M Trautmann-Rodriguez, N Gill… - Advanced Drug Delivery …, 2023 - Elsevier
Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …
Macrophage implication in IPF: updates on immune, epigenetic, and metabolic pathways
Idiopathic pulmonary fibrosis (IPF) is a lethal interstitial lung disease of unknown etiology
with a poor prognosis. It is a chronic and progressive disease that has a distinct radiological …
with a poor prognosis. It is a chronic and progressive disease that has a distinct radiological …
Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis
Abstract Background The Wnt signaling pathway has been implicated in the pathogenesis of
fibrotic disorders and malignancies. Hence, we aimed to assess the potential of the induced …
fibrotic disorders and malignancies. Hence, we aimed to assess the potential of the induced …
Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis
Mesenchymal cells in the lung are crucial during development, but also contribute to the
pathogenesis of fibrotic disorders, including idiopathic pulmonary fibrosis (IPF), the most …
pathogenesis of fibrotic disorders, including idiopathic pulmonary fibrosis (IPF), the most …
Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases
D Mokra, J Mokry, R Barosova, J Hanusrichterova - Antioxidants, 2023 - mdpi.com
N-acetylcysteine (NAC) is widely used because of its mucolytic effects, taking part in the
therapeutic protocols of cystic fibrosis. NAC is also administered as an antidote in …
therapeutic protocols of cystic fibrosis. NAC is also administered as an antidote in …
Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease
L Wang, Y Zhang, Z Song, Q Liu, D Fan, X Song - Food & Function, 2023 - pubs.rsc.org
Lung cancer is the malignancy with the highest morbidity and mortality. Additionally,
pulmonary inflammatory diseases, such as pneumonia, acute lung injury, chronic obstructive …
pulmonary inflammatory diseases, such as pneumonia, acute lung injury, chronic obstructive …
Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis
Y Yang, H Huang, Y Li - Frontiers in Pharmacology, 2022 - frontiersin.org
Pulmonary fibrosis is a chronic, progressive fibrosing interstitial lung disease of unknown
etiology that leads rapidly to death. It is characterized by the replacement of healthy tissue …
etiology that leads rapidly to death. It is characterized by the replacement of healthy tissue …
Recent advances in intestinal fibrosis
Despite many progresses have been made in the treatment of inflammatory bowel disease,
especially due to the increasing number of effective therapies, the development of tissue …
especially due to the increasing number of effective therapies, the development of tissue …
The role of macrophages in connective tissue disease-associated interstitial lung disease: focusing on molecular mechanisms and potential treatment strategies
CC Tseng, YW Sung, KY Chen, PY Wang… - International Journal of …, 2023 - mdpi.com
Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a severe
manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can …
manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can …